DHG Pharmaceutical JSC (STC:DHG) Total Equity: ₫4,442,942 Mil (As of Mar. 2026)


STC:DHG DHG Pharmaceutical JSC STC:DHG
78 GF Score
Price ₫93,800.00
GF Value ₫113,390.11
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DHG Pharmaceutical JSC Total Equity?

DHG Pharmaceutical JSC STC:DHG 78 Total Equity is ₫4,442,942 Mil as of Mar. 2026. GuruFocus rates STC:DHG with a GF Score™ of 78/100 and a GF Value™ of ₫113,390.11 (Modestly Undervalued). The stock has 4 warning signs investors should review.

DHG Pharmaceutical JSC's total equity for the quarter that ended in Mar. 2026 was ₫4,442,942 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

DHG Pharmaceutical JSC Total Equity Historical Data

* Premium members only.

The historical data trend for DHG Pharmaceutical JSC's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DHG Pharmaceutical JSC Total Equity Chart

DHG Pharmaceutical JSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,790,010.10 4,291,536.90 4,852,934.67 4,094,755.10 4,137,265.18

DHG Pharmaceutical JSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,360,994.95 3,788,045.78 3,997,690.06 4,137,265.18 4,442,942.46
STC:DHG
78GF Score
DHG Pharmaceutical JSC STC:DHG
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DHG Pharmaceutical JSC Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

DHG Pharmaceutical JSC's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=5173881.629-1036616.453
=4,137,265

DHG Pharmaceutical JSC's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=5245728.16-802785.703
=4,442,942

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₫4,442,942 Mil mean?
DHG Pharmaceutical JSC (STC:DHG) has a Total Equity of ₫4,442,942 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for DHG Pharmaceutical JSC and its competitors.
Is DHG Pharmaceutical JSC's Total Equity too high?
DHG Pharmaceutical JSC's current Total Equity is ₫4,442,942 Mil. Overall, DHG Pharmaceutical JSC has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DHG Pharmaceutical JSC's Total Equity compare to ZTS and UTHR?
DHG Pharmaceutical JSC's Total Equity of ₫4,442,942 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for DHG Pharmaceutical JSC and its competitors. DHG Pharmaceutical JSC's current Total Equity is ₫4,442,942 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DHG Pharmaceutical JSC stock overvalued right now?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC (STC:DHG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫113,390.11, compared to a current price of ₫93,800.00 — trading 17.3% below its estimated fair value. The current Total Equity is ₫4,442,942 Mil. DHG Pharmaceutical JSC's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For DHG Pharmaceutical JSC (STC:DHG), the current Total Equity is ₫4,442,942 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DHG Pharmaceutical JSC (STC:DHG) Overvalued in 2026?

Based on GuruFocus' analysis, DHG Pharmaceutical JSC stock appears to be undervalued. The current stock price of ₫93,800.00 is trading 17.3% below its estimated GF Value™ of ₫113,390.11. GuruFocus considers DHG Pharmaceutical JSC to be Modestly Undervalued.

Key valuation signals for STC:DHG:

  • Total Equity: ₫4,442,942 Mil
  • GF Value™: ₫113,390.11 vs. price of ₫93,800.00 (17.3% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the STC:DHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DHG Pharmaceutical JSC Business Description

Address 288 Bis Nguyen Van Cu, An Hoa Ward, Ninh Kieu District, Can Tho, VNM
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotics, antifungals, and antiparasitics; analgesics and antipyretics; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
78GF Score

Get the complete analysis for STC:DHG

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫93,800.00
Price
₫113,390.11
GF Value